• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸代谢障碍性疾病——从基础病理生理学到治疗学进展。

Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.

机构信息

Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Dis Model Mech. 2023 Nov 1;16(11). doi: 10.1242/dmm.050233. Epub 2023 Nov 23.

DOI:10.1242/dmm.050233
PMID:37994477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10690057/
Abstract

Amino acids are organic molecules that serve as basic substrates for protein synthesis and have additional key roles in a diverse array of cellular functions, including cell signaling, gene expression, energy production and molecular biosynthesis. Genetic defects in the synthesis, catabolism or transport of amino acids underlie a diverse class of diseases known as inborn errors of amino acid metabolism. Individually, these disorders are rare, but collectively, they represent an important group of potentially treatable disorders. In this Clinical Puzzle, we discuss the pathophysiology, clinical features and management of three disorders that showcase the diverse clinical presentations of disorders of amino acid metabolism: phenylketonuria, lysinuric protein intolerance and homocystinuria due to cystathionine β-synthase (CBS) deficiency. Understanding the biochemical perturbations caused by defects in amino acid metabolism will contribute to ongoing development of diagnostic and management strategies aimed at improving the morbidity and mortality associated with this diverse group of disorders.

摘要

氨基酸是有机分子,它们作为蛋白质合成的基本底物,并在多种细胞功能中具有额外的关键作用,包括细胞信号转导、基因表达、能量产生和分子生物合成。氨基酸合成、分解代谢或运输的遗传缺陷是一类称为氨基酸代谢先天错误的多种疾病的基础。这些疾病单独发生的情况很少见,但总体而言,它们代表了一组重要的、具有潜在可治疗性的疾病。在这个临床谜题中,我们讨论了三种疾病的病理生理学、临床特征和管理,这些疾病展示了氨基酸代谢紊乱的不同临床表现:苯丙酮尿症、赖氨酸尿蛋白不耐受症和胱硫醚β-合成酶(CBS)缺乏引起的高胱氨酸尿症。了解氨基酸代谢缺陷引起的生化紊乱将有助于不断发展旨在改善与这一组多种疾病相关的发病率和死亡率的诊断和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d3/10690057/2655ebf80e76/dmm-16-050233-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d3/10690057/2655ebf80e76/dmm-16-050233-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d3/10690057/2655ebf80e76/dmm-16-050233-g1.jpg

相似文献

1
Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.氨基酸代谢障碍性疾病——从基础病理生理学到治疗学进展。
Dis Model Mech. 2023 Nov 1;16(11). doi: 10.1242/dmm.050233. Epub 2023 Nov 23.
2
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.可治疗的导致智力障碍的先天性代谢缺陷:系统文献回顾。
Mol Genet Metab. 2012 Mar;105(3):368-81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30.
5
Disorders of Intracellular Cobalamin Metabolism细胞内钴胺素代谢紊乱
6
Ornithine Transcarbamylase Deficiency鸟氨酸转氨甲酰酶缺乏症
7
Maple Syrup Urine Disease枫糖尿症
8
Electrophoresis电泳
9
Citrullinemia Type II型瓜氨酸血症
10
Newborn screening for homocystinuria.同型胱氨酸尿症的新生儿筛查。
Cochrane Database Syst Rev. 2015 Oct 1;2015(10):CD008840. doi: 10.1002/14651858.CD008840.pub4.

引用本文的文献

1
Single Amino Acid Supplementation in Inherited Metabolic Disorders: An Evidence-Based Review of Interventions.遗传性代谢疾病中的单一氨基酸补充:基于证据的干预措施综述。
Genes (Basel). 2025 Apr 27;16(5):502. doi: 10.3390/genes16050502.
2
A novel, high throughput, and low-cost method for the detection of 40 amines relevant to inborn errors of metabolism, in under 60 min, using reverse phase high performance liquid chromatography.一种新颖、高通量且低成本的方法,用于在不到60分钟的时间内,使用反相高效液相色谱法检测与先天性代谢缺陷相关的40种胺类物质。
Mol Genet Metab Rep. 2025 Feb 28;43:101202. doi: 10.1016/j.ymgmr.2025.101202. eCollection 2025 Jun.
3

本文引用的文献

1
Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria.治疗胱硫醚β合酶缺乏型高胱氨酸尿症的新策略。
Br J Pharmacol. 2023 Feb;180(3):264-278. doi: 10.1111/bph.15991. Epub 2022 Dec 8.
2
Homocystinuria diagnosis and management: it is not all classical.同型胱氨酸尿症的诊断与管理:并非全是典型的。
J Clin Pathol. 2022 Sep 19. doi: 10.1136/jcp-2021-208029.
3
Present and future of lipid nanoparticle-mRNA technology in phenylketonuria disease treatment.脂质纳米颗粒-mRNA 技术在苯丙酮尿症治疗中的现状与展望。
Evaluation of bone mineral density and biochemical markers in pediatric patients with phenylketonuria.
苯丙酮尿症患儿骨密度及生化标志物的评估
Mol Genet Metab Rep. 2024 Dec 8;41:101173. doi: 10.1016/j.ymgmr.2024.101173. eCollection 2024 Dec.
4
The Effects of Mesenchymal Stem Cells-Derived Exosomes on Metabolic Reprogramming in Scar Formation and Wound Healing.间充质干细胞衍生的外泌体对瘢痕形成和伤口愈合代谢重编程的影响。
Int J Nanomedicine. 2024 Sep 24;19:9871-9887. doi: 10.2147/IJN.S480901. eCollection 2024.
5
Navigating social determinants of health barriers in the management of phenylketonuria.在苯丙酮尿症管理中应对健康障碍的社会决定因素
Mol Genet Metab Rep. 2024 May 3;39(Suppl 1):101080. doi: 10.1016/j.ymgmr.2024.101080. eCollection 2024 Aug.
6
Hemophagocytic Lymphohistiocytosis in Lysinuric Protein Intolerance.赖氨酸尿性蛋白不耐受症中的噬血细胞性淋巴组织细胞增生症
Indian J Pediatr. 2024 Dec;91(12):1292. doi: 10.1007/s12098-024-05215-w. Epub 2024 Aug 1.
Int Rev Cell Mol Biol. 2022;372:159-174. doi: 10.1016/bs.ircmb.2022.04.008. Epub 2022 Jun 3.
4
A Silk-Based Platform to Stabilize Phenylalanine Ammonia-lyase for Orally Administered Enzyme Replacement Therapy.基于丝素的平台稳定苯丙氨酸解氨酶用于口服酶替代疗法。
Mol Pharm. 2022 Dec 5;19(12):4625-4630. doi: 10.1021/acs.molpharmaceut.2c00512. Epub 2022 Jul 21.
5
Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model.脂质纳米颗粒将苯丙氨酸解氨酶mRNA递送至肝脏,从而在苯丙酮尿症小鼠模型中导致苯丙氨酸的分解代谢和清除。
Mol Genet Metab Rep. 2022 May 14;32:100882. doi: 10.1016/j.ymgmr.2022.100882. eCollection 2022 Sep.
6
Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity.苯丙酮尿症氧化应激和能量失调:新兴的病理生理因素提供了干预机会。
Mol Genet Metab. 2022 Jun;136(2):111-117. doi: 10.1016/j.ymgme.2022.03.012. Epub 2022 Mar 29.
7
The diagnostic challenge of mild citrulline elevation at newborn screening.新生儿筛查中轻度瓜氨酸升高的诊断挑战。
Mol Genet Metab. 2022 Apr;135(4):327-332. doi: 10.1016/j.ymgme.2022.02.008. Epub 2022 Feb 20.
8
Early Development of Newborn Screening for HCU and Current Challenges.先天性高胱氨酸尿症新生儿筛查的早期发展及当前挑战。
Int J Neonatal Screen. 2021 Oct 25;7(4):67. doi: 10.3390/ijns7040067.
9
Long-term functional correction of cystathionine β-synthase deficiency in mice by adeno-associated viral gene therapy.腺相关病毒基因治疗纠正胱硫醚β-合酶缺乏症小鼠的长期功能障碍。
J Inherit Metab Dis. 2021 Nov;44(6):1382-1392. doi: 10.1002/jimd.12437. Epub 2021 Oct 11.
10
Milestones in treatments for inborn errors of metabolism: Reflections on Where chemistry and medicine meet.代谢缺陷治疗的里程碑:化学与医学的交汇点反思。
Am J Med Genet A. 2021 Nov;185(11):3350-3358. doi: 10.1002/ajmg.a.62385. Epub 2021 Jun 24.